Papillary thyroid cancer

Current Treatment Options in Oncology

Volumn 7, Issue 4, 2006, Pages 309-319

  Caron, Nadine R ^b   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; CATECHOLAMINE DERIVATIVE; COLESTYRAMINE; DIGITALIS; FATTY ACID; HISTONE DEACETYLASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; RESVERATROL; RETINOID; ROSIGLITAZONE; THYROGLOBULIN; THYROTROPIN; VALPROIC ACID;

ANGINA PECTORIS; ATELECTASIS; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FEVER; DRUG HALF LIFE; DRUG POTENTIATION; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; FACE EDEMA; FLU LIKE SYNDROME; FLUSHING; FOLLOW UP; GENE THERAPY; HEADACHE; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPERHIDROSIS; HYPERTHYROIDISM; HYPOGEUSIA; HYPOTHYROIDISM; LACRIMAL DUCT OCCLUSION; LEUKEMIA; LEUKOPENIA; MENSTRUAL IRREGULARITY; MUCOSA INFLAMMATION; NAUSEA; NERVOUSNESS; OLIGOSPERMIA; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PRURITUS; RADIATION PNEUMONIA; REVIEW; SALIVARY GLAND CANCER; SEROMA; SIALOADENITIS; SIDE EFFECT; SKIN FIBROSIS; SKIN MANIFESTATION; SMALL INTESTINE CANCER; SPINAL CORD INJURY; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; THYROID FOLLICLE CELL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROIDITIS; TRACHEA OBSTRUCTION; URINARY TRACT INFECTION; URTICARIA; VOMITING; WOUND INFECTION; XEROSTOMIA;

ANTINEOPLASTIC AGENTS; CARCINOMA, PAPILLARY; CLINICAL TRIALS; HUMANS; RADIOTHERAPY; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33745901052     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0040-7     Document Type: Review

References (24)

1. Silver RJ, Parangi A: Management of thyroid incidentalomas. Surg Clin North Am 2004, 84:907-919.
2. Baskin HJ: Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules and multinodular goiters. Endocr Pract 2004, 10:242-245.
3. Agrawal S: Diagnostic accuracy and role of fine needle aspiration cytology in management of thyroid nodules. J Surg Oncol 1995, 58:168-172.
4. Woeber KA: Cost-effective evaluation of the patient with a thyroid nodule. Surg Clin North Am 1995, 75:357-363.
5. Punthakee X, Palme CE, Franklin JH, et al.: Fine-needle aspiration biopsy findings suspicious for papillary thyroid carcinoma: a review of cytopathological criteria. Laryngoscope 2005, 115:433-436.
6. Brierley JD, Tsang RW: External radiation therapy in the treatment of thyroid malignancy. Endocrinol Metab Clin North Am 1996, 25:141-157.
7. Ringel MD, Ladenson PW: Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004, 11:97-116.
8. Repchinsky C: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals, vol. 537. Ottawa, Canada: CP Association; 2004:1948-1951.
9. Caron NR, Clark OH: Well differentiated thyroid cancer. Scand J Surg 2004, 93:261-271.
10. Kebebew E, Clark OH: Differentiated thyroid cancer: "complete" rational approach. World J Surg 2000, 24:942-951.
11. Caron NR, Clark OH: Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 2005, 6:311-322.
12. Angelos P: Current approaches to the treatment of well-differentiated thyroid cancer. Oncology (Williston Park) 2002, 16:309-315; discussion 315, 318, 323-324.
13. Dackiw AP, Zeiger M: Extent of surgery for differentiated thyroid cancer. Surg Clin North Am 2004, 84:817-832.
14. Caron NR, Tan YY, Ogilvie JB et al.: Selective modified radical neck dissection for papillary thyroid cancer - is level I, II and V dissection always necessary? World J Surg 2006, 30:1-8.
15. Caron NR, Sturgeon C, Clark OH: The specialist endocrine surgeon. In Practical Management of Thyroid Cancer - A Multidisciplinary Approach. Edited by Mazzaferri EL. London: Springer; 2005:121-134.
16. Weigel RJ: Advances in the diagnosis and management of well-differentiated thyroid cancers. Curr Opin Oncol 1996, 8:37-43.
17. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97:418-428.
18. Wartofsky L, Sherman SI, Gopal J, et al.: The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998, 83:4195-4203.
19. Cailleux AF, Baudin E, Travagli JP, et al.: Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000, 85:175-178.
20. Loh KC, Greenspan FS, Gee L, et al.: Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Ciin Endocrinol Metab 1997, 82:3553-3562.
21. Ford D, Giridharan S, McConkey C, et al.: External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2003, 15:337-341.
22. Hay ID: Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990, 19:545-576.
23. Kebebew E, Clark OH: Papillary thyroid cancer. In Surgical Endocrinology. Edited by Doherty GM, Skogseid B. Philadelphia: Lippincott Williams & Wilkins; 2001:59-73.
24. Park JW, Clark OH: Redifferentiation therapy for thyroid cancer. Surg Clin North Am 2004, 84:921-943.